Keiji Nishida

This inventor holds 9 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Kobe University, Nippon Shokubai Co., Ltd.. Active years: 2020-2026.

USPTO Granted Patents = 9 (Patent Applications = 10)

% Patents Active = 88.9

CIPO Patents = 4

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)

Company Filing History:

Nippon Shokubai Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12716076 - METHOD FOR INCREASING MUTATION INTRODUCTION EFFICIENCY IN GENOME SEQUENCE MODIFICATION TECHNIQUE, AND MOLECULAR COMPLEX TO BE USED THEREFOR (2026-08-25),

2. 12139730 - Complex for genome editing having stability and few side-effects, and nucleic acid coding same (2024-11-12),

3. 11845953 - Method for converting nucleic acid sequence of cell specifically converting nucleic acid base of targeted DNA using cell endogenous DNA modifying enzyme, and molecular complex used therein (2023-12-19),

4. 11718846 - Genomic sequence modification method for specifically converting nucleic acid bases of targeted DNA sequence, and molecular complex for use in same (2023-08-08),

5. 11220693 - Method for converting monocot plant genome sequence in which nucleic acid base in targeted DNA sequence is specifically converted, and molecular complex used therein (2022-01-11),

6. 11041169 - Method for modifying target site in double-stranded DNA in cell (2021-06-22),

7. 10920215 - Method for modifying genome sequence to introduce specific mutation to targeted DNA sequence by base-removal reaction, and molecular complex used therein (2021-02-16),

8. 10767173 - Method for converting genome sequence of gram-positive bacterium by specifically converting nucleic acid base of targeted DNA sequence, and molecular complex used in same (2020-09-08),

9. 10655123 - Genomic sequence modification method for specifically converting nucleic acid bases of targeted DNA sequence, and molecular complex for use in same (2020-05-19),

Title: Keiji Nishida: Innovator in Genome Editing

Introduction

Keiji Nishida is a prominent inventor based in Kobe, Japan, known for his significant contributions to the field of genome editing. With a total of eight patents to his name, Nishida has made remarkable advancements that aim to improve the precision and efficacy of genetic modifications.

Latest Patents

Nishida's latest patents include a complex for genome editing that boasts stability and minimal side effects. This invention provides a complex containing a nucleic acid sequence-recognizing module linked to a proteolysis tag. The module specifically binds to a target nucleotide sequence in double-stranded DNA, while the tag consists of a peptide containing three hydrophobic amino acid residues at the C-terminal or a peptide with three amino acid residues at the C-terminal, where at least part of the residues is substituted by serine. Another notable patent is a method for converting nucleic acid sequences in cells, which involves stimulating the cell with a factor that induces an endogenous DNA modifying enzyme. This method allows for the alteration of targeted DNA sites by converting, deleting, or inserting nucleotides.

Career Highlights

Throughout his career, Nishida has worked with esteemed institutions such as Kobe University and Nippon Shokubai Co., Ltd. His work has been pivotal in advancing the understanding and application of genome editing technologies.

Collaborations

Nishida has collaborated with notable colleagues, including Akihiko Kondo and Satomi Kojima, contributing to the innovative research in his field.

Conclusion

Keiji Nishida's contributions to genome editing exemplify the potential of innovative technologies in transforming genetic research and applications. His patents reflect a commitment to enhancing the safety and effectiveness of genetic modifications, marking him as a key figure in the scientific community.